Cowen And Company, LLC Bristol Myers Squibb CO Transaction History

Cowen And Company, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $596,460 - $706,293	-8,710 Reduced 61.95%	5,349 $384,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $1,170 - $691,944	9,005 Added 178.18%	14,059 $999,000
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $698,677 - $769,487	-9,621 Reduced 65.56%	5,054 $389,000
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $293,075 - $351,423	4,767 Added 48.11%	14,675 $1.07 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1.42 Million - $1.65 Million	-26,405 Reduced 72.72%	9,908 $618,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $2.15 Million - $2.52 Million	36,313 New	36,313 $2.15 Million
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $4,640 - $6,743	-100 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $4,921 - $6,419	100 New	100 $6,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.